Literature DB >> 17036377

Gene therapy of liver cancer.

Ruben Hernandez-Alcoceba1, Bruno Sangro, Jesus Prieto.   

Abstract

The application of gene transfer technologies to the treatment of cancer has led to the development of new experimental approaches like gene directed enzyme/pro-drug therapy (GDEPT), inhibition of oncogenes and restoration of tumor-suppressor genes. In addition, gene therapy has a big impact on other fields like cancer immunotherapy, anti-angiogenic therapy and virotherapy. These strategies are being evaluated for the treatment of primary and metastatic liver cancer and some of them have reached clinical phases. We present a review on the basis and the actual status of gene therapy approaches applied to liver cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17036377      PMCID: PMC4088099          DOI: 10.3748/wjg.v12.i38.6085

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  168 in total

1.  An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.

Authors:  John L Jakubczak; Patricia Ryan; Mario Gorziglia; Lori Clarke; Lynda K Hawkins; Carl Hay; Ying Huang; Michele Kaloss; Anthony Marinov; Sandrina Phipps; Anne Pinkstaff; Pamela Shirley; Yelena Skripchenko; David Stewart; Suzanne Forry-Schaudies; Paul L Hallenbeck
Journal:  Cancer Res       Date:  2003-04-01       Impact factor: 12.701

Review 2.  Combined interventional therapies of hepatocellular carcinoma.

Authors:  Jun Qian; Gan-Sheng Feng; Thomas Vogl
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

Review 3.  Viral oncolysis for malignant liver tumors.

Authors:  John T Mullen; Kenneth K Tanabe
Journal:  Ann Surg Oncol       Date:  2003-07       Impact factor: 5.344

4.  Concurrent delivery of GM-CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors.

Authors:  Kuo-Feng Tai; Pei-Jer Chen; Ding-Shinn Chen; Lih-Hwa Hwang
Journal:  J Gene Med       Date:  2003-05       Impact factor: 4.565

5.  In vitro and in vivo activities of an oncolytic adenoviral vector designed to express GM-CSF.

Authors:  J Andrew Bristol; Mingzhu Zhu; Hong Ji; Mervat Mina; Yuefeng Xie; Lori Clarke; Suzanne Forry-Schaudies; David L Ennist
Journal:  Mol Ther       Date:  2003-06       Impact factor: 11.454

6.  Liver failure caused by herpes simplex virus thymidine kinase plus ganciclovir therapy is associated with mitochondrial dysfunction and mitochondrial DNA depletion.

Authors:  Maite Herraiz; Naiara Beraza; Abelardo Solano; Bruno Sangro; Julio Montoya; Cheng Qian; Jesus Prieto; Matilde Bustos
Journal:  Hum Gene Ther       Date:  2003-03-20       Impact factor: 5.695

7.  Phase II trial of intravenous CI-1042 in patients with metastatic colorectal cancer.

Authors:  Oday Hamid; Mary L Varterasian; Scott Wadler; J Randolph Hecht; Al Benson; Evanthia Galanis; Margaret Uprichard; Charles Omer; Paul Bycott; Robert C Hackman; Anthony F Shields
Journal:  J Clin Oncol       Date:  2003-04-15       Impact factor: 44.544

8.  A telomerase-dependent conditionally replicating adenovirus for selective treatment of cancer.

Authors:  Thomas Wirth; Lars Zender; Bernd Schulte; Bettina Mundt; Ruben Plentz; Karl Lenhard Rudolph; Michael Manns; Stefan Kubicka; Florian Kühnel
Journal:  Cancer Res       Date:  2003-06-15       Impact factor: 12.701

9.  Neoadjuvant treatment of hepatic malignancy: an oncolytic herpes simplex virus expressing IL-12 effectively treats the parent tumor and protects against recurrence-after resection.

Authors:  W R Jarnagin; J S Zager; D Klimstra; K A Delman; S Malhotra; M Ebright; S Little; B DeRubertis; S F Stanziale; M Hezel; H Federoff; Y Fong
Journal:  Cancer Gene Ther       Date:  2003-03       Impact factor: 5.987

10.  Pancreatic cancer escape variants that evade immunogene therapy through loss of sensitivity to IFNgamma-induced apoptosis.

Authors:  G Mazzolini; I Narvaiza; L A Martinez-Cruz; A Arina; M Barajas; J C Galofré; C Qian; J M Mato; J Prieto; I Melero
Journal:  Gene Ther       Date:  2003-07       Impact factor: 5.250

View more
  11 in total

1.  p53-expressing conditionally replicative adenovirus CNHK500-p53 against hepatocellular carcinoma in vitro.

Authors:  Hong-Chuan Zhao; Qi Zhang; Yang Yang; Min-Qiang Lu; Hua Li; Chi Xu; Gui-Hua Chen
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

2.  Adenoviral gene therapy in hepatocellular carcinoma: a review.

Authors:  Iván Lyra-González; Laura Esther Flores-Fong; Ignacio González-García; David Medina-Preciado; Juan Armendáriz-Borunda
Journal:  Hepatol Int       Date:  2012-04-25       Impact factor: 6.047

3.  Vascular damage and anti-angiogenic effects of tumor vessel-targeted adenovirus-mediated herpes simplex virus thymidine kinase gene.

Authors:  Bao-Jin Li; Chao Zhang; Yuan-Xue Yi; Ying Hao; Xiao-Ping Liu; Qing-Jia Ou
Journal:  World J Gastroenterol       Date:  2007-08-07       Impact factor: 5.742

Review 4.  Advances in experimental and translational research in the treatment of hepatocellular carcinoma.

Authors:  Travis Kidner; Menghua Dai; Prasad S Adusumilli; Yuman Fong
Journal:  Surg Oncol Clin N Am       Date:  2008-04       Impact factor: 3.495

5.  Antitumor efficacy of C-X-C motif chemokine ligand 14 in hepatocellular carcinoma in vitro and in vivo.

Authors:  Weilin Wang; Pengfei Huang; Lufei Zhang; Jianfeng Wei; Qingsong Xie; Qiang Sun; Xiaohu Zhou; Haiyang Xie; Lin Zhou; Shusen Zheng
Journal:  Cancer Sci       Date:  2013-10-14       Impact factor: 6.716

6.  Comparison of caspase genes for the induction of apoptosis following gene delivery.

Authors:  Xiujuan Zhang; Curlicia Turner; W T Godbey
Journal:  Mol Biotechnol       Date:  2008-12-09       Impact factor: 2.695

7.  Preferential targeting of disseminated liver tumors using a recombinant adeno-associated viral vector.

Authors:  Marco Della Peruta; Adam Badar; Cecilia Rosales; Shilpa Chokshi; Azadeh Kia; Devhrut Nathwani; Eva Galante; Ran Yan; Erik Arstad; Andrew M Davidoff; Roger Williams; Mark F Lythgoe; Amit C Nathwani
Journal:  Hum Gene Ther       Date:  2015-02       Impact factor: 5.695

Review 8.  Therapeutic potential of stem cells expressing suicide genes that selectively target human breast cancer cells: evidence that they exert tumoricidal effects via tumor tropism (review).

Authors:  Bo-Rim Yi; Kelvin J Choi; Seung U Kim; Kyung-Chul Choi
Journal:  Int J Oncol       Date:  2012-06-20       Impact factor: 5.650

9.  Targeting Gene-Viro-Therapy with AFP driving Apoptin gene shows potent antitumor effect in hepatocarcinoma.

Authors:  Kang-Jian Zhang; Jing Qian; Shi-Bing Wang; Yi Yang
Journal:  J Biomed Sci       Date:  2012-02-09       Impact factor: 8.410

10.  BCL6B expression in hepatocellular carcinoma and its efficacy in the inhibition of liver damage and fibrogenesis.

Authors:  Weilin Wang; Pengfei Huang; Panyisha Wu; Rong Kong; Jiang Xu; Lufei Zhang; Qifan Yang; Qingsong Xie; Linshi Zhang; Xiaohu Zhou; Linghui Chen; Haiyang Xie; Lin Zhou; Shusen Zheng
Journal:  Oncotarget       Date:  2015-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.